Pages that link to "Item:Q7979"
Jump to navigation
Jump to search
The following pages link to Methods (Q7979):
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Methods section from DOI: 10.1186/s13613-020-00653-z (Q8291) (← links)
- Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265) (Q8399) (← links)
- Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8400) (← links)
- Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) (Q8401) (← links)
- Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) (Q8402) (← links)
- Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) (Q8403) (← links)
- Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265) (Q8404) (← links)
- Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) (Q8405) (← links)
- Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) (Q8406) (← links)
- Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265) (Q8407) (← links)
- Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8408) (← links)
- Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8409) (← links)
- Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8410) (← links)
- Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8411) (← links)
- Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265) (Q8412) (← links)
- Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8413) (← links)
- Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8414) (← links)
- Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) (Q8415) (← links)
- Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8416) (← links)
- Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) (Q8417) (← links)
- Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) (Q8418) (← links)
- Section 2. Traditional Methods of Diagnosing Infections (from DOI: 10.3390/v12020211) (Q10063) (← links)
- Section 3. Studying Viral Pathogens with High Throughput Sequencing (HTS) (from DOI: 10.3390/v12020211) (Q10064) (← links)
- Section 3.1. Metagenomic Approach (from DOI: 10.3390/v12020211) (Q10065) (← links)
- Section 3.2. Problems of Metagenomic Approach (from DOI: 10.3390/v12020211) (Q10066) (← links)
- Section 3.3. Methods for Improving Sequencing Output (from DOI: 10.3390/v12020211) (Q10067) (← links)
- Section 3.3.1. Nucleic Acids Depletion (from DOI: 10.3390/v12020211) (Q10068) (← links)
- Section 3.3.2. Hybridization-Based Enrichment (from DOI: 10.3390/v12020211) (Q10069) (← links)
- Section 3.3.3. Target Amplification (from DOI: 10.3390/v12020211) (Q10070) (← links)
- Section 3.4. Whole Viral Genome Sequencing (from DOI: 10.3390/v12020211) (Q10071) (← links)
- Section 3.5. Methods of Sequencing Data Analysis (from DOI: 10.3390/v12020211) (Q10072) (← links)
- Section 4. Long Read Sequencing (from DOI: 10.3390/v12020211) (Q10073) (← links)
- Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) (Q10740) (← links)
- Section 2: Methods (from DOI:10.14218/ERHM.2020.00023) (Q10799) (← links)
- Section 2: Methods (from DOI: 10.1016/j.adro.2020.04.015) (Q11168) (← links)